Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism by Cribbs, AP, Terlecki-Zaniewicz, S, Philpott, M, Baardman, J, Ahern, D, Lindow, M, Obad, S, Oerum, H, Sampey, B, Mander, PK, Penn, H, Wordsworth, P, Bowness, P, De Winther, M, Prinjha, RK, Feldmann, M, Oppermann, U

Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors by Booth, CAG, Barkas, N, Neo, WH, Boukarabila, H, Soilleux, EJ, Giotopoulos, G, Farnoud, N, Giustacchini, A, Ashley, N, Carrelha, J, Jamieson, L, Atkinson, D, Bouriez-Jones, T, Prinjha, RK, Milne, TA, Teachey, DT, Papaemmanuil, E, Huntly, BJP, Jacobsen, SEW, Mead, AJ

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762 by Chaidos, A, Caputo, V, Gouvedenou, K, Liu, B, Marigo, I, Chaudhry, M, Rotolo, A, Tough, DF, Smithers, NN, Bassil, AK, Chapman, TD, Harker, NR, Barbash, O, Tummino, P, Al-Mahdi, N, Haynes, AC, Cutler, L, Le, B, Rahemtulla, A, Roberts, I, Kleijnen, M, Witherington, J, Parr, NJ, Prinjha, RK, Karadimitris, A